NASDAQ
Total Transactions
21
7 buys /14 sells
Shares Acquired
82,555
Transactions: 7•Avg: 11,793.57
Shares Disposed
119,847
Transactions: 14•Avg: 8,560.5
Net Activity
-37,292
Net Selling•Ratio: 50%
Q4 2025(Current) | 82,555 | 119,847 | -37,292 | 50.00% |
Q3 2025 | 532,559 | 119,851 | +412,708 | 54.55% |
Q2 2025 | 557,219 | 133,099 | +424,120 | 100.00% |
Q1 2025 | 1,392,870 | 731,453 | +661,417 | 80.95% |
Q4 2024 | 102,633 | 176,291 | -73,658 | 50.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 37,292 shares•Acquired/Disposed Ratio: 50%
Net Activity | |||||
|---|---|---|---|---|---|
RCM Roche Corleen M. | Officer: chief financial officer | 3 | 450,000 | 0 | +450,000 |
KDG Kirby Daniel Gordon | Officer: chief commercial officer | 5 | 335,000 | 0 | +335,000 |
DID Dukes Iain D. | Director | 1 | 135,092 | 0 | +135,092 |
RMW Rosinack Matthew W. | Officer: svp, finance (int. pfo & pao) | 3 | 0 | 134,060 | -134,060 |
PRK Puri Raj K. | Officer: chief regulatory officer | 17 | 207,531 | 114,635 | +92,896 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-01 | Officer: chief medical officer | Purchase | 8,789 | $0 | $0 | 114,198 | |
2025-12-02 | Officer: chief medical officer | Purchase | 3,906 | $0 | $0 | 113,640 | |
2025-12-02 | Officer: chief medical officer | Sale | 1,984 | $2.14 | $4,245.76 | 111,656 | |
2025-12-01 | Officer: chief medical officer | Sale | 4,464 | $2.23 | $9,954.72 | 109,734 | |
2025-12-01 | Officer: chief medical officer | Sale | 8,789 | $0 | $0 | 43,949 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
GFF GRAF FINCKENSTEIN FRIEDRICH | Officer: chief medical officer | Dec 3, 2025 | |
GFF GRAF FINCKENSTEIN FRIEDRICH | Officer: chief medical officer | Dec 3, 2025 | |
GFF GRAF FINCKENSTEIN FRIEDRICH | Officer: chief medical officer | Dec 3, 2025 | |
GFF GRAF FINCKENSTEIN FRIEDRICH | Officer: chief medical officer | Dec 3, 2025 | |
GFF GRAF FINCKENSTEIN FRIEDRICH | Officer: chief medical officer | Dec 3, 2025 |
Net change in shares shown on right
No price data available for this timeframe.